Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 16 | 2026 | 750 | 3.000 |
Why?
|
| Genetic Vectors | 13 | 2026 | 917 | 2.560 |
Why?
|
| Genetic Therapy | 12 | 2026 | 838 | 1.860 |
Why?
|
| Muscular Atrophy, Spinal | 2 | 2026 | 25 | 1.740 |
Why?
|
| Gene Silencing | 4 | 2026 | 430 | 1.520 |
Why?
|
| MicroRNAs | 8 | 2026 | 710 | 1.490 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2026 | 12 | 0.970 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2026 | 148 | 0.920 |
Why?
|
| Liver Failure, Acute | 1 | 2025 | 25 | 0.910 |
Why?
|
| Acetaminophen | 1 | 2025 | 52 | 0.880 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2025 | 53 | 0.870 |
Why?
|
| Disease Models, Animal | 8 | 2026 | 2281 | 0.740 |
Why?
|
| Mice | 20 | 2026 | 11088 | 0.680 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2026 | 515 | 0.670 |
Why?
|
| Genome, Viral | 2 | 2019 | 144 | 0.620 |
Why?
|
| Transgenes | 4 | 2026 | 204 | 0.600 |
Why?
|
| Gene Expression Regulation | 1 | 2025 | 1629 | 0.560 |
Why?
|
| Animals | 24 | 2026 | 21292 | 0.540 |
Why?
|
| Inverted Repeat Sequences | 1 | 2017 | 14 | 0.520 |
Why?
|
| Osteoporosis | 3 | 2024 | 113 | 0.510 |
Why?
|
| DNA, Viral | 1 | 2017 | 231 | 0.480 |
Why?
|
| Motor Neurons | 2 | 2026 | 218 | 0.400 |
Why?
|
| Myositis Ossificans | 2 | 2023 | 7 | 0.390 |
Why?
|
| Promoter Regions, Genetic | 2 | 2026 | 687 | 0.360 |
Why?
|
| Gene Editing | 3 | 2024 | 327 | 0.340 |
Why?
|
| Liver | 3 | 2025 | 868 | 0.290 |
Why?
|
| Humans | 21 | 2026 | 64958 | 0.280 |
Why?
|
| Nucleic Acid Conformation | 2 | 2019 | 243 | 0.260 |
Why?
|
| Mice, Transgenic | 3 | 2026 | 1287 | 0.250 |
Why?
|
| Schistosomiasis | 2 | 2018 | 5 | 0.250 |
Why?
|
| Activin Receptors, Type I | 2 | 2023 | 15 | 0.250 |
Why?
|
| Transduction, Genetic | 2 | 2019 | 243 | 0.240 |
Why?
|
| Macaca mulatta | 2 | 2024 | 260 | 0.240 |
Why?
|
| Male | 10 | 2026 | 30957 | 0.240 |
Why?
|
| Administration, Intravenous | 1 | 2026 | 71 | 0.240 |
Why?
|
| Neuromuscular Junction | 1 | 2026 | 83 | 0.230 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2025 | 15 | 0.230 |
Why?
|
| Glutathione Transferase | 1 | 2025 | 38 | 0.230 |
Why?
|
| Capsid | 3 | 2023 | 104 | 0.220 |
Why?
|
| Gene Expression | 2 | 2019 | 852 | 0.220 |
Why?
|
| Alveolar Bone Loss | 1 | 2024 | 4 | 0.210 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2026 | 500 | 0.210 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2026 | 176 | 0.210 |
Why?
|
| Adenine | 1 | 2024 | 48 | 0.200 |
Why?
|
| CRISPR-Cas Systems | 2 | 2024 | 368 | 0.200 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2024 | 44 | 0.200 |
Why?
|
| Liver Neoplasms | 1 | 2026 | 309 | 0.200 |
Why?
|
| Nanopores | 1 | 2022 | 14 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 3 | 2026 | 3469 | 0.190 |
Why?
|
| Ossification, Heterotopic | 1 | 2022 | 14 | 0.190 |
Why?
|
| Bone and Bones | 2 | 2022 | 152 | 0.180 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 1224 | 0.180 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 980 | 0.180 |
Why?
|
| Mitochondrial Myopathies | 1 | 2021 | 4 | 0.180 |
Why?
|
| Thymidine Kinase | 1 | 2021 | 18 | 0.180 |
Why?
|
| Gene Transfer Techniques | 3 | 2021 | 325 | 0.170 |
Why?
|
| Codon, Nonsense | 1 | 2022 | 62 | 0.170 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 217 | 0.170 |
Why?
|
| Fractures, Bone | 1 | 2022 | 138 | 0.170 |
Why?
|
| Gene Order | 2 | 2019 | 33 | 0.170 |
Why?
|
| Hepatic Stellate Cells | 2 | 2018 | 25 | 0.160 |
Why?
|
| Bone Resorption | 1 | 2019 | 46 | 0.150 |
Why?
|
| Lung | 1 | 2024 | 962 | 0.150 |
Why?
|
| Dopaminergic Neurons | 1 | 2019 | 37 | 0.150 |
Why?
|
| RNA Stability | 1 | 2019 | 104 | 0.150 |
Why?
|
| Infant | 1 | 2024 | 1683 | 0.140 |
Why?
|
| Capsid Proteins | 1 | 2020 | 107 | 0.140 |
Why?
|
| Corpus Striatum | 1 | 2019 | 98 | 0.140 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2019 | 43 | 0.140 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 79 | 0.140 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 105 | 0.140 |
Why?
|
| Cocaine | 1 | 2019 | 101 | 0.140 |
Why?
|
| RNA, Viral | 1 | 2019 | 266 | 0.140 |
Why?
|
| Schistosoma | 1 | 2018 | 3 | 0.140 |
Why?
|
| Interleukin-33 | 1 | 2018 | 19 | 0.140 |
Why?
|
| Mitochondria | 1 | 2021 | 401 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2019 | 211 | 0.130 |
Why?
|
| Sequence Deletion | 1 | 2017 | 115 | 0.130 |
Why?
|
| Female | 4 | 2026 | 33929 | 0.120 |
Why?
|
| Cell Line | 2 | 2019 | 2021 | 0.120 |
Why?
|
| Genes, Reporter | 1 | 2017 | 257 | 0.120 |
Why?
|
| Plasmids | 1 | 2017 | 294 | 0.120 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2017 | 92 | 0.120 |
Why?
|
| RNA Interference | 1 | 2019 | 643 | 0.120 |
Why?
|
| Adenoviridae | 3 | 2022 | 130 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 414 | 0.110 |
Why?
|
| Liver Diseases, Parasitic | 1 | 2015 | 4 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 2015 | 37 | 0.110 |
Why?
|
| DNA Replication | 1 | 2017 | 247 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 61 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 2012 | 30 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2012 | 33 | 0.110 |
Why?
|
| Translocation, Genetic | 2 | 2012 | 74 | 0.100 |
Why?
|
| Receptors, AMPA | 1 | 2013 | 42 | 0.090 |
Why?
|
| Amygdala | 1 | 2013 | 85 | 0.090 |
Why?
|
| Reward | 1 | 2013 | 89 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2012 | 32 | 0.090 |
Why?
|
| Boronic Acids | 1 | 2012 | 28 | 0.090 |
Why?
|
| Osteogenesis | 2 | 2023 | 154 | 0.090 |
Why?
|
| Pyrazines | 1 | 2012 | 35 | 0.090 |
Why?
|
| Models, Biological | 1 | 2017 | 1192 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 869 | 0.090 |
Why?
|
| Leukemia | 1 | 2012 | 62 | 0.090 |
Why?
|
| Learning | 1 | 2013 | 185 | 0.080 |
Why?
|
| Osteoblasts | 2 | 2024 | 205 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 440 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2017 | 1551 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2020 | 615 | 0.070 |
Why?
|
| Diterpenes, Kaurane | 1 | 2006 | 2 | 0.060 |
Why?
|
| Diterpenes | 1 | 2006 | 13 | 0.060 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2006 | 82 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2006 | 64 | 0.060 |
Why?
|
| Apoptosis | 2 | 2012 | 1100 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2018 | 324 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 750 | 0.060 |
Why?
|
| Utrophin | 1 | 2024 | 4 | 0.050 |
Why?
|
| Mice, Inbred mdx | 1 | 2024 | 16 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2006 | 191 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2188 | 0.050 |
Why?
|
| Dystrophin | 1 | 2024 | 30 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 121 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 86 | 0.050 |
Why?
|
| Mutation | 2 | 2022 | 2657 | 0.050 |
Why?
|
| Activins | 1 | 2023 | 55 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 293 | 0.050 |
Why?
|
| Terminal Repeat Sequences | 1 | 2022 | 13 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2022 | 23 | 0.050 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2022 | 26 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2024 | 229 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2022 | 37 | 0.040 |
Why?
|
| Compassionate Use Trials | 1 | 2021 | 2 | 0.040 |
Why?
|
| Thymidine | 1 | 2021 | 25 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 642 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2022 | 93 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 86 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 426 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 394 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 90 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 87 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2019 | 62 | 0.040 |
Why?
|
| Serogroup | 1 | 2019 | 35 | 0.040 |
Why?
|
| Cartilage | 1 | 2019 | 35 | 0.040 |
Why?
|
| DNA | 1 | 2024 | 857 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2019 | 198 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2024 | 770 | 0.040 |
Why?
|
| Locomotion | 1 | 2019 | 111 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2019 | 113 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2019 | 311 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 217 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 297 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 312 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 367 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 1589 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2017 | 222 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1161 | 0.030 |
Why?
|
| Smad7 Protein | 1 | 2015 | 1 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2021 | 819 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1138 | 0.030 |
Why?
|
| Extinction, Psychological | 1 | 2013 | 14 | 0.020 |
Why?
|
| Adult | 2 | 2022 | 17314 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2013 | 46 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2013 | 133 | 0.020 |
Why?
|
| Morphine | 1 | 2013 | 60 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 182 | 0.020 |
Why?
|
| Bortezomib | 1 | 2012 | 58 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 373 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 610 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 895 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 1601 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 961 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 1989 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 526 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1639 | 0.020 |
Why?
|
| U937 Cells | 1 | 2006 | 10 | 0.020 |
Why?
|
| RUNX1 Translocation Partner 1 Protein | 1 | 2006 | 11 | 0.020 |
Why?
|
| Cytarabine | 1 | 2006 | 36 | 0.020 |
Why?
|
| Plants, Medicinal | 1 | 2006 | 19 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2006 | 44 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 142 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2006 | 77 | 0.020 |
Why?
|
| United States | 1 | 2020 | 8085 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2006 | 287 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2006 | 130 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 14926 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 18210 | 0.010 |
Why?
|